7.66
+0.55
+(7.74%)
At close: 4:00:01 PM EDT
7.66
0.00
(0.00%)
After hours: 4:05:12 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.3 | -0.27 | -1.12 | -1.38 |
| Low Estimate | -0.34 | -0.35 | -1.46 | -1.78 |
| High Estimate | -0.26 | -0.19 | -0.79 | -0.98 |
| Year Ago EPS | -- | -- | -3.26 | -1.12 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2024 |
|---|---|
| EPS Est. | -0.29 |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.3 | -0.27 | -1.12 | -1.38 |
| 7 Days Ago | 0 | 0 | -1.2 | -1.49 |
| 30 Days Ago | 0 | 0 | -1.2 | -1.49 |
| 60 Days Ago | 0 | 0 | -1.2 | -1.49 |
| 90 Days Ago | 0 | 0 | -1.2 | -1.49 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACTU | -- | -- | 65.49% | -22.67% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Initiated | HC Wainwright & Co.: Buy | 3/17/2025 |
Related Tickers
RNTX Rein Therapeutics Inc.
1.7100
+9.62%
COYA Coya Therapeutics, Inc.
5.17
+4.87%
CUE Cue Biopharma, Inc.
0.7661
+6.58%
GYRE Gyre Therapeutics, Inc.
7.52
+3.16%
INAB IN8bio, Inc.
0.1521
+3.40%
LTRN Lantern Pharma Inc.
3.2100
+5.59%
APTO Aptose Biosciences Inc.
1.7100
0.00%
CGTX Cognition Therapeutics, Inc.
0.3529
+10.49%
JUNS Jupiter Neurosciences, Inc.
0.5314
-3.21%
NRXS NeurAxis, Inc.
1.7900
0.00%